Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 2 More Arrow 1,859
Earnings before taxes -44,054 More Arrow -40,726 Less Arrow -52,142
EBITDA -44,176 More Arrow -40,724 Less Arrow -51,233
Total assets 26,763 More Arrow 36,679 More Arrow 52,786
Current assets 24,915 More Arrow 33,650 More Arrow 50,717
Current liabilities 7,949 Less Arrow 6,526 Less Arrow 6,059
Equity capital 18,814 More Arrow 30,153 More Arrow 46,727
- share capital 5,736 Less Arrow 2,557 More Arrow 27,448
Employees (average) 4 More Arrow 5 Equal arrow 5

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 70.3% More Arrow 82.2% More Arrow 88.5%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -164.6% More Arrow -111.0% More Arrow -95.3%
Current ratio 313.4% More Arrow 515.6% More Arrow 837.1%
Return on equity (ROE) -234.2% More Arrow -135.1% More Arrow -111.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 More Arrow 1
Chg. No. of employees % -20% More Arrow 0% More Arrow 25%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.